Bovie Medical Corporation Announces Marketing And Distribution Alliances With Medline Industries, Inc.
The program is being rolled out as group purchasing organizations and integrated delivery network contract renewals are re-negotiated.
Commenting on the alliance, Andrew Makrides CEO of Bovie Medical stated, "This alliance offers a significant value proposition to hospitals and hospital buying groups by emphasizing the strengths of both companies. Hospitals will have access to Bovie's advanced electrosurgical equipment as well as Medline's high quality accessories."
"We're excited to be working with Bovie Medical, a recognized leader in the electrosurgical market. This partnership further supports our mission to help improve patient care and the quality of peoples' lives by providing quality medical products with superior value to healthcare providers and end users," said Medline Anesthesia and OR Necessities Division President Jim O'Brien.
Mr. Makrides continued, "This alliance offers a one stop solution to the end user plus gives group purchasing organizations additional choices to offer to their members."
About Bovie Medical
Bovie Medical, Corp. (www.boviemedical.com), headquartered in Melville, NY with manufacturing in St. Petersburg, FL, is a developer, manufacturer and marketer of electrosurgical products.
About Medline
Medline, headquartered in Mundelein, IL, with more than $2 billion in annual revenues, manufactures and distributes more than 100,000 products to hospitals, extended care facilities, surgery centers, home care dealers and agencies and other markets. Medline has more than 700 dedicated sales representatives nationwide to support its broad product line and cost management services. For more information on Medline, visit www.medline.com.
This document may contain some forward looking statements, particularly regarding operational prospects in 2006 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings.
Contact: Investor Relations: Buttonwood Advisory Group, Inc. John Aneralla, 800/940-9087
Source: Bovie Medical Corporation